Passage BIO, Inc. Quarterly Debt-to-equity in % from Q3 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Passage BIO, Inc. quarterly Debt-to-equity history and growth rate from Q3 2020 to Q3 2024.
  • Passage BIO, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 39.2 %, a 48.4% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 39.2 +12.8 +48.4% Sep 30, 2024
Q2 2024 35.3 +12 +51.3% Jun 30, 2024
Q1 2024 32.7 +11.1 +51.6% Mar 31, 2024
Q4 2023 30.2 +10.2 +50.7% Dec 31, 2023
Q3 2023 26.4 +9.14 +52.9% Sep 30, 2023
Q2 2023 23.3 +9.39 +67.5% Jun 30, 2023
Q1 2023 21.6 +10.3 +90.7% Mar 31, 2023
Q4 2022 20 +11.7 +142% Dec 31, 2022
Q3 2022 17.3 +9.81 +131% Sep 30, 2022
Q2 2022 13.9 +6.92 +99% Jun 30, 2022
Q1 2022 11.3 +5.69 +101% Mar 31, 2022
Q4 2021 8.27 +3.71 +81.4% Dec 31, 2021
Q3 2021 7.48 +3.17 +73.5% Sep 30, 2021
Q2 2021 6.99 Jun 30, 2021
Q1 2021 5.62 Mar 31, 2021
Q4 2020 4.56 Dec 31, 2020
Q3 2020 4.31 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.